相关实验视频

Updated: Sep 14, 2025

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

氧化马丁用于治疗亚托皮炎:网络药理学,生物信息学,代谢学和实验验证

Jin Huang¹, Hongxia Li², Jiqiang Liang²

¹Shenzhen Pingle Orthopedic Hospital (Shenzhen Pingshan Traditional Chinese Medicine Hospital), Shenzhen 518001, China; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.

International immunopharmacology

|July 18, 2025

概括

氧化马 (OMT) 通过减少皮肤病变和抑制炎症因素,有效治疗阿托皮炎 (AD). 这项研究阐明了OMT的机制,强调了它在乳腺细胞稳定和AD治疗的免疫路径调节中的作用.

科学领域:

药理学药理学是指药理学的学科.
免疫学免疫学免疫学
皮肤病学皮肤病学

背景情况:

索波拉 (Sophora flavescens Aiton) 是一种广泛用于治疗亚托皮炎 (AD) 的草药.
氧氨酸 (OMT) 是Sophora flavescens Aiton的一个关键成分,在AD中具有不清楚的治疗作用和机制.
这项研究研究了OMT在AD模型中的有效性和作用.

研究的目的:

为了评估oxymatrine (OMT) 的抗皮炎 (AD) 作用.
阐明OMT在治疗AD中的作用机制.
探索OMT对AD免疫细胞因子和代谢概况的影响.

主要方法:

在Cavia porcellus中使用2,4-Dinitrochlorobenzene (DNCB) 或Ovalbumin (OVA) 建立了AD模型.
评估了皮肤炎得分,组织病理学和免疫细胞因子.
生物信息学,网络药理学和血代谢学被用来探索OMT的机制.

主要成果:

在DNCB和OVA诱导的AD模型中,OMT表现出显著的抗皮活性,减少皮肤病变和炎症性细胞因子表达.
代谢分析揭示了与炎症相关的脂质,胺和谷氨代谢的变化.
生物信息学确定了12个常见的点,这些点涉及IL-2,IL-17,IL-10,IL-4和IL-13信号通路,这对于巨细胞降粒至关重要.

结论:

OMT有效地抑制巨细胞脱粒化,并减少炎症介质的释放,如组胺和细胞因子.
这些发现证实了OMT通过调节关键炎症通路来治疗亚托皮炎的治疗潜力.

关键词:

亚托邦性皮肤炎 (Atopic Dermatitis) 是一种不良的疾病.巨细胞的脱粒化代谢学代谢学代谢学网络药理学网络药理学氧化氨酸是一种氧化氨酸.

更多相关视频

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

相关概念视频

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Cholinergic Antagonists: Pharmacokinetics

Cholinergic Antagonists: Pharmacokinetics

Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...

Cholinergic Antagonists: Therapeutic Uses

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...